DR. AMORY VEDRAN NOVOSELAC M.D. NPI 1699852962

NPI Details

DR. Amory Vedran Novoselac, M.D. is a hematology and oncology internal medicine in New York, NY with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Amory Vedran Novoselac, M.D. NPI is 1699852962. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

12 E 86TH ST
OFC 4
NEW YORK, NY
ZIP 10028-506
Phone: (212) 861-6660
Fax: (212) 744-4696

The NPI 1699852962 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Protein measurement, serum (HCPCS:84165)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Ige (immune system protein) level (HCPCS:82785)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood count, manual test (HCPCS:85044)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, clotting time (HCPCS:85610)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Folic acid level, serum (HCPCS:82746)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Vitamin d-3 level (HCPCS:82306)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Acute hepatitis panel (HCPCS:80074)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Bilirubin level, total (HCPCS:82247)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Drawing of blood for a medical problem (HCPCS:99195)
• Hemoglobin a1c level (HCPCS:83036)
• Urinalysis, manual test (HCPCS:81002)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Testosterone (hormone) level, total (HCPCS:84403)
• Rheumatoid factor level (HCPCS:86431)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Blood smear for iron (HCPCS:85536)

The enumeration date for this NPI number is 11/1/2006 and was last updated on 5/31/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.